1. Home
  2. FENC vs DMF Comparison

FENC vs DMF Comparison

Compare FENC & DMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FENC
  • DMF
  • Stock Information
  • Founded
  • FENC 1996
  • DMF 1988
  • Country
  • FENC United States
  • DMF United States
  • Employees
  • FENC N/A
  • DMF N/A
  • Industry
  • FENC Biotechnology: Biological Products (No Diagnostic Substances)
  • DMF Finance/Investors Services
  • Sector
  • FENC Health Care
  • DMF Finance
  • Exchange
  • FENC Nasdaq
  • DMF Nasdaq
  • Market Cap
  • FENC 181.7M
  • DMF 149.3M
  • IPO Year
  • FENC 2001
  • DMF N/A
  • Fundamental
  • Price
  • FENC $3.99
  • DMF $7.25
  • Analyst Decision
  • FENC Strong Buy
  • DMF
  • Analyst Count
  • FENC 2
  • DMF 0
  • Target Price
  • FENC $14.00
  • DMF N/A
  • AVG Volume (30 Days)
  • FENC 116.0K
  • DMF 60.7K
  • Earning Date
  • FENC 11-07-2024
  • DMF 01-01-0001
  • Dividend Yield
  • FENC N/A
  • DMF 2.66%
  • EPS Growth
  • FENC N/A
  • DMF N/A
  • EPS
  • FENC N/A
  • DMF 0.15
  • Revenue
  • FENC $49,348,000.00
  • DMF N/A
  • Revenue This Year
  • FENC $116.50
  • DMF N/A
  • Revenue Next Year
  • FENC $17.49
  • DMF N/A
  • P/E Ratio
  • FENC N/A
  • DMF $45.13
  • Revenue Growth
  • FENC 278.09
  • DMF N/A
  • 52 Week Low
  • FENC $3.97
  • DMF $5.37
  • 52 Week High
  • FENC $11.92
  • DMF $6.79
  • Technical
  • Relative Strength Index (RSI)
  • FENC 38.47
  • DMF 50.67
  • Support Level
  • FENC $3.99
  • DMF $7.04
  • Resistance Level
  • FENC $4.57
  • DMF $7.30
  • Average True Range (ATR)
  • FENC 0.31
  • DMF 0.08
  • MACD
  • FENC -0.02
  • DMF 0.01
  • Stochastic Oscillator
  • FENC 2.33
  • DMF 77.78

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

About DMF BNY Mellon Municipal Income Inc.

BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.

Share on Social Networks: